Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

PMS-ABIRATERONE - Health Canada Drug Approval Details

Approvals/Health Canada/PMS-ABIRATERONE

Authorized

STANDARD

PMS-ABIRATERONE

Pharmascience Inc🇨🇦 Health Canada

Approval Date: Apr 6, 2026
Approval ID: 4532887d44a82554
Company: Pharmascience Inc
Type: Standard

Approval Details

Approval Id: 4532887d44a82554
Drug Approval Canada Name: PMS-ABIRATERONE
Product Name: PMS-ABIRATERONE
Status: Marketed
Status Date: 2021-01-11
Original Market Date: 2021-01-11
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: PRESCRIPTION
Ahfs: 10:00.00
Atc Original: L02BX03 ABIRATERONE
Aig Number: 0152948002
Company Name: Pharmascience Inc
Company Address: 100 6111 Royalmount Ave Montreal Quebec Canada H4P 2T4
Company Detail Path: /organization/pharmascience-inc

Company Information

Pharmaceutical Company Name: Pharmascience Inc
Country Name: Canada
Province Name: Quebec
City Name: montréal,quebec,country_ca
Address: 6111 av Royalmount bureau 100

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Apr 6, 2026

Approval ID

4532887d44a82554

Type

Standard

Back to Health Canada Approvals